GMED EBITDA Growth
52.84%TTM
Period ending:
GMED TTM EBITDA YoY %%
107.94%-41.75%
2012-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
GMED ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 55 observations from Dec 31, 2012 to Jun 30, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 52.8364% | |
| 59.4749% | |
| 72.958% | |
| 69.2338% | |
| 56.7974% | |
| 55.1886% | |
| 36.3082% | |
| 29.2685% | |
| 23.9162% | |
| 12.9277% | |
| 13.8192% | |
| 22.1467% | |
| 21.0456% | |
| 21.8436% | |
| 15.0262% | |
| -10.2041% | |
| -11.0369% | |
| 25.0258% | |
| 48.4334% | |
| 83.981% | |
| 93.4524% | |
| -5.5987% | |
| -20.8308% | |
| -25.7242% | |
| -27.2601% | |
| 3.5439% | |
| 3.9169% | |
| 0.2523% | |
| -2.6251% | |
| 1.9372% | |
| 5.5476% | |
| 8.7161% | |
| 7.7352% | |
| 5.587% | |
| 6.422% | |
| -0.8802% | |
| -1.5339% | |
| -2.6605% | |
| -1.3253% | |
| 16.313% | |
| 21.4173% | |
| 24.9215% | |
| 25.7288% | |
| 11.5521% | |
| 11.2096% | |
| 9.2885% | |
| 7.9348% | |
| 15.2981% | |
| 13.5284% | |
| 11.5945% | |
| 9.756% | |
| 5.5927% | |
| 4.1298% | |
| 9.1149% | |
| 13.4021% |
Compare ebitda growth
All GMED financial metrics · GMED stock overview · How to interpret financial metrics
